CME Group — Q2 2026 Earnings Preview
BUY
NASDAQ: CME | A de-risked print: Q2 volume already public (29.8M ADV, 2nd-highest Q2 ever); the debate is rate-per-contract mix, not the top line. Expect another small beat vs. a conservative $3.01 / $1.74B consensus.
Earnings Date
Jul 22
BMO · 11 days out (from Jul 11)
Consensus EPS
$3.01
+1.7% YoY · $1.74B rev (18 analysts)
Internal EPS
~$3.05
Small beat likely — 12/12 beat streak
Implied Move
n/a
Options data unavailable; +0.5% last Q
Executive summary
CME Group reports FY2026Q2 on Wednesday, July 22, 2026 (before market open) — the earliest reporter in the exchange complex, so there is little same-quarter peer read ahead of it. This is a de-risked print: because CME publishes monthly volume, the quarter's single biggest driver is already public. Q2'26 total ADV of 29.8M contracts was the second-highest Q2 ever — yet ~1.4% below the year-ago record (30.2M) because April-2026 (25.9M) laps the "Liberation Day" tariff-volatility spike of April-2025. May (33.2M, +15%) and June (30.6M, +19%) re-accelerated hard, so the quarter builds momentum into Q3.
Trajectory: consensus implies a sharp optical deceleration — from Q1'26's +14.5% revenue / +20.0% EPS (record 36.2M ADV) to +2.8% revenue / +1.7% EPS in Q2'26. This is a tough-comp artifact, not a fundamental crack: the franchise is lapping its own tariff-shock record. CME remains the dominant global-derivatives leader with a 72.8% record adjusted operating margin, a capital-efficiency moat, and 32+ straight quarters of market-data growth. Consensus of +2.8% / +1.7% looks conservative against known volumes plus double-digit market-data growth.
What to watch: (1) rate-per-contract (RPC) mix — the most likely source of a small revenue miss despite known ADV (blended RPC drifted from $0.69 in Q2'25 to $0.652 in Q1'26 on volume tiering + crude/micro mix); (2) whether management holds or nudges the $1.695B annual expense guide (Dallas occupancy + Google Cloud costs build through 2H); (3) any update on the June 17 CEO succession (Duffy → Executive Chairman Mar 2027; CFO Fitzpatrick → CEO) and the still-unfilled CFO seat; (4) forward optionality — 24/7 crypto, tokenized collateral, prediction markets, and FMX rate competition.
Guidance & estimates
CME issues no revenue, EPS, or margin guidance — the top line is a mechanical function of macro-driven trading volume (ADV × rate per contract). Its only forward guidance is annual and expense/capital-focused, set on the Q4'25 call (Feb 4, 2026) and affirmed on the Q1'26 call (Apr 22, 2026). So the honest "guide-vs-actual" exercise is expenses; the market's de-facto guide for the volume-driven lines is consensus.
FY2026 annual guidance (the only hard guide CME gives)
| Guided metric (FY2026, annual) | Guide | Prior-yr (FY2025) | Implied YoY | Status |
|---|---|---|---|---|
| Adj. opex ex-license fees | ~$1.695B | ~$1.625B | +4.3% | Affirmed Q1'26 |
| Capital expenditures | ~$85M | — | — | Set Q4'25 |
| Adj. effective tax rate | 23.5%–24.5% | 23.7% | ~flat | Set Q4'25 |
| Fee-change revenue uplift | +1.0% to +1.5% | — | on 2025 activity | Set Q4'25 |
FY2026Q2 consensus vs. the YoY base (the number that matters)
| Metric | Consensus Q2'26 | FY2025Q2 base | Implied YoY | vs. Q1'26 actual |
|---|---|---|---|---|
| Revenue | $1.74B | $1,692.0M | +2.8% | +14.5% |
| Diluted EPS (adj.) | $3.01 | $2.96 | +1.7% | +20.0% |
| Total ADV (K contracts) | 29,800 (reported) | 30,217 | −1.4% | +21.7% |
Expense guide: FY2025 guided $1.65B → lowered twice → delivered ~$1.625B (a $25M / 1.5% beat vs. original) — disciplined, reliably-beaten cost management. Consensus (18 analysts) is a web aggregate (Bloomberg/Visible Alpha MCPs offline this run); prior-year actuals from Daloopa (company_id 333).
Detailed key metrics
(a) Current quarter (FY2026Q2) — revenue drivers → consolidated
CME issues no guide on any line, so "Guide" columns are omitted. Driver-level ADV cells show the FY2025Q2 YoY base the Street models off. % Diff = implied YoY.
| Metric | Consensus / expected | Q2'25 base | Driver |
|---|---|---|---|
| Interest rates ADV | macro-driven | 15,472 | Jun +17% |
| Equities ADV | macro-driven | 7,661 | Jun +54% (rec) |
| Energy ADV | macro-driven | 3,082 | Jun +26% |
| Agricultural ADV | macro-driven | 1,964 | rec Jun |
| Metals ADV | macro-driven | 943 | Jun +12% |
| FX ADV | macro-driven | 1,096 | — |
| Total ADV | 29,800 (reported) | 30,217 | −1.4% YoY |
| Avg rate per contract (RPC) | mix-driven (watch) | $0.69 | Q1'26 $0.652 |
| Clearing & transaction fees | ~$1.44B* | $1,388.0M | ~80% of rev |
| Market data & info services | ~$0.22B* | $198.1M | 32 up-Qs |
| Total revenue | $1.74B | $1,692.0M | +2.8% |
| Diluted EPS (adj.) | $3.01 | $2.96 | +1.7% |
*C&T fees / market-data / margin lines are not separately consensus-published; approximations implied from the $1.74B consensus and recent mix — directional, not sourced estimates.
(b) FQ+1 guide (FY2026Q3, expected)
| Metric | Guide | Consensus |
|---|---|---|
| Revenue / EPS / margin / ADV | Not guided | n/a (not retrieved this run) |
CME gives no quarterly guidance. The only forward guide spanning Q3 is the standing annual guide (below). Watch whether management re-affirms or raises the $1.695B expense guide on the Q2 call — the one guidance datapoint that moves.
(c) FY+1 guide (FY2026 full-year — standing guide)
| Metric | Guide (mid) | Consensus | % Diff |
|---|---|---|---|
| Adj. opex ex-license | $1.695B | company-set | +4.3% vs FY25 |
| Capital expenditures | $85M | company-set | — |
| Adj. effective tax rate | 24.0% | company-set | ~flat |
| Total revenue | Not guided | ~$6.9–7.0B | ~+7% vs $6.5B |
| Diluted EPS (adj.) | Not guided | ~$12.40 (range $11.90–12.90) | vs ~$11.29 FY25 |
Guide figures annual, set Feb 4, 2026, affirmed Apr 22, 2026 (CME earnings calls). FY revenue/EPS consensus is a web aggregate with wide analyst dispersion (last-resort; not a company figure). FY2025 actuals from CME Q4'25 call.
Set-up analysis
Tone: peak confidence. CME heads into the Q2 print with the most confident tone in years. Q1'26 was a clean sweep of all-time records — the first quarter ever with simultaneous records in all six asset classes — and management repeatedly used "record-breaking," "always risk on," and "never been more optimistic." Adjusted operating margin hit a company-record 72.8%. Across five consecutive calls, tone has been consistently high; the only cyclical softening was Q3'25 (a natural give-back after the tariff-vol Q2'25, revenue −3% YoY), and it stayed constructive, not defensive. No guidance withdrawn, no margin worry — no red flags per the investing framework.
Post-guidance updates since the Q1 call (Apr 22, 2026)
1. CEO succession (Jun 17, 2026) — the one real new development
Terry Duffy (CEO since 2006) transitions to Executive Chairman effective Mar 1, 2027; President & CFO Lynne Fitzpatrick appointed CEO (first woman to lead CME) and joins the board. Orderly, internal, well-telegraphed handoff with a ~9-month runway and Duffy staying on = continuity, not a pre-earnings red flag. Stock fell ~4.9% on the day partly on succession uncertainty + sector regulatory noise. Open item: no successor CFO named — the one governance loose end to watch.
2. Monthly volume prints define the setup
April 25.9M (soft — laps Apr-2025 tariff spike) → May 33.2M (all-time May record, +15%) → June 30.6M (record June, +19%; equity index +54% to record 10.1M; crypto +76% YoY). Q2 total 29.8M = second-highest Q2 ever, ~flat to slightly down on the record comp. Strong exit rate into Q3.
3. Expenses are the metric to watch
Q1 adj. opex ex-license grew ~7% YoY (variable comp + technology on record activity). Management framed it as activity-driven and reaffirmed ~$1.695B, but flagged occupancy stepping up (Dallas facility, summer 2026) and technology (Google Cloud) through 2H. Watch whether they hold, nudge, or lean toward the high end.
4. RPC decline is "a feature, not a bug"
Volume tiering lowers rate-per-contract at high volumes but "drives highly profitable incremental volume." Q1'26 RPC $0.652 (vs $0.707 in Q4'25). Duffy urged analysts to "focus on that just a little bit more … this is a really good thing." Assume continued RPC drift down — a beat should come from volume/mix, not rate.
5. Risk flagged by management: perpetual-futures competition
Duffy's most emphatic caveat (Q1 call + escalated at Piper Sandler Jun 4): argues perps are illegal in the US under the Commodity Exchange Act, criticizes offshore auto-liquidation models and EU retail leverage. Also flagged an S&P DJI JV granting an exclusive S&P 500 perp license to a third party without notifying CME (CME owns 27% of the index business) — an IP/partner friction "being worked through." Prediction-markets regulatory overhang (CFTC) is a secondary watch.
Sources: CME FY2026Q1 & FY2025Q4 earnings transcripts (shared folder); CME/PRNewswire monthly-volume releases (Apr–Jun 2026); CEO-succession press release (Jun 17, 2026); Piper Sandler conference (Jun 4, 2026). Fundamentals from Daloopa (company_id 333).
Key catalysts
The biggest catalyst is already public: Q2 ADV (29.8M) was released Jul 2, three weeks before the print. The July 22 debate is therefore NOT "what were volumes" but RPC mix, the tough comp, non-transaction lines, and forward optionality.
| Catalyst | Latest KPI (Daloopa) | Read for Q2'26 |
|---|---|---|
| Total ADV / txn fees (~80% rev) | Q1'26 36,231K; Q2'25 30,217K | Q2'26 29.8M already reported; growth optically decelerates on the tariff comp — volumes de-risked |
| Interest-rate complex + Fed path | IR rev Q1'26 $521.2M vs Q2'25 $461.6M | Jun IR ADV +17%; Treasury OI at all-time high — durable, structural demand |
| Equity index + micro-option settlement | Equity rev Q1'26 $315.6M | June equity-index ADV +54% to a record 10.1M — the standout Q2 line |
| Energy (Iran / Hormuz / Venezuela) | Energy rev Q1'26 $263.7M vs Q2'25 $217.4M | Jun +26%; WTI share >79–80%. Supply-shock vol = tailwind but watch RPC drag |
| Metals (gold/silver vol) | Metals rev Q1'26 $118.4M vs Q2'25 $85.1M | Fastest-growing line YoY; sticky retail micro adoption |
| Crypto — 24/7 live (May 29) | New disclosure line (BTC/ETH futures & options) | Q2 crypto ADV +32%, June +76% YoY. Small $ today; clearest forward optionality |
| Market data (recurring, sticky) | Q1'26 $224.1M (+15%) vs Q2'25 $198.1M | 32 consecutive up-quarters; de-risks the mix vs volatile txn fees |
| Collateral / float income | Q1 cash ~$149B @ 33bps; non-cash ~$171B @ 10bps | Held ~33bps in April; balances up QoQ. A Fed cut pressures the spread — under-modeled swing |
| FMX competition (rate rival) | FMX SOFR ADV ~39K in Q1'26 (from 2.2K yr-ago) | Still <1% of CME rate volume; counter = FICC cross-margining live Apr 30 (~80% margin savings). Watch share commentary |
| Capital return / OSTTRA proceeds | $3.2B returned in Q1; ~$758M OSTTRA cash remaining | Variable dividend + opportunistic buyback supports EPS; watch buyback pace |
Sources: reported financials & KPIs — Daloopa company_id 333 (cited inline). Q2 2026 volume (already public): CME/PR Newswire, Jul 2, 2026. Consensus: CME_consensus.json (web aggregate, last resort — Bloomberg/VA MCPs offline).
News analysis
| Date | Headline | Commentary |
|---|---|---|
| Jun 17 | CEO succession: Duffy → Exec Chairman (Mar 2027); CFO Fitzpatrick named next CEO | Biggest item of the period. Internal promotion signals continuity; stock fell ~4.9% on the day. Opens a CFO search. |
| Jul 2 | Record June ADV 30.6M (+19%); second-highest Q2 ever | Directly de-risks the Jul 22 print. Equity-index & ag hit all-time June highs; supports the top line vs. $1.74B / $3.01 consensus. |
| Jun 30 | Single-stock futures to launch July 27 (55 standard + 22 micro, 50+ US names) | New surface in the equity complex; extends into a Cboe/ICE zone. Multi-quarter ramp — not a near-term needle-mover. |
| Jun 29 | Financially-settled Micro E-mini S&P 500 & Nasdaq-100 options launched | Broadens the retail-friendly micro equity-index suite — a key RPC/volume driver. |
| May 29 | 24/7 crypto futures & options trading went live | June crypto ADV +76% YoY. Small % of revenue but fast-growing and strategically important. |
| Q4'26 launch | Treasury Link announced — connects Treasury futures & cash liquidity pools | Deepens the dominant rates franchise (BrokerTec + Treasury futures); pending regulatory review. |
| Mid-2026 | Regulatory scrutiny of perpetual futures; CFTC review of 24/7 oil proposal | Sector-wide overhang that compounded the Jun 17 selloff. A gating factor on new-product cadence — key risk to monitor. |
Net read: the dominant non-earnings story is the Jun 17 CEO succession (internal, orderly, but pressured the stock). Fundamentally the tape is constructive into the Jul 22 print — record May/June volumes and a strong crypto/equity-index mix support consensus. New-product breadth is strategically positive but back-half/2027-weighted. Regulatory review of 24/7 and perpetual-style contracts is the key overhang.
Sources: company press releases and reputable financial media (CNBC, PR Newswire, Investing.com, StockTitan, The Block) as linked. No fundamental figures fabricated.
Beat/miss track record
Consistent beater — 12/12 EPS beats over 12 quarters (100%); 4/4 over the last 4. But beat magnitude is compressing (avg EPS surprise ~+3.2% in 2023 → ~+1.3% over the last 4 quarters) as the Street learned to model published ADV. Beats now come from rate-per-contract mix, market-data momentum, and operating leverage — not the top line. Set-up read: expect another small beat vs. $3.01 EPS / $1.74B consensus.
| Metric | Q2'23 | Q3'23 | Q4'23 | Q1'24 | Q2'24 | Q3'24 | Q4'24 | Q1'25 | Q2'25 | Q3'25 | Q4'25 | Q1'26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS surprise | +5.5% | +1.8% | +4.4% | ~+1.2% | +2.0% | +1.1% | +3.3% | +4.5% | +1.0% | +1.9% | +0.7% | +1.5% |
| Revenue surprise | +1.5% | n/a | n/a | +0.8% | n/a | n/a | n/a | +3.3% | +0.7% | n/a | n/a | +1.6% |
Green = beat; darker = larger surprise. No misses observed. Grey = consensus not reliably archived (Bloomberg/VA offline). Scale: ≥+4% dark, +2–4% medium, +1–2% light, <+1% pale.
| Window | Avg EPS surprise | Read |
|---|---|---|
| Q2'23–Q1'24 (oldest 4) | ~+3.2% | Big beats when volatility/volume surprised the Street |
| Q2'24–Q1'25 (middle 4) | ~+2.7% | Still solid — rate-per-contract mix + margin |
| Q2'25–Q1'26 (last 4) | ~+1.3% | Beats compress — consensus now models published ADV accurately |
Actuals — Daloopa (company_id 333, adjusted diluted EPS & non-GAAP revenue, cited in Task 7). Consensus/surprise — Zacks/aggregated Street at report date (Bloomberg & Visible Alpha MCPs offline this run — flagged). Management commentary — CME FY2026Q1 earnings call (Apr 22, 2026).
Data sourced from Daloopa (company_id 333), CME earnings transcripts, CME/PR Newswire volume releases, and web-aggregated consensus (last resort). Prepared July 11, 2026 for the FY2026Q2 print on July 22, 2026 (BMO).